Skip to main content
. Author manuscript; available in PMC: 2020 Feb 28.
Published in final edited form as: Am J Nephrol. 2019 Feb 28;49(4):263–270. doi: 10.1159/000497445

Table 3.

Hazard ratios (95% CI) for all-cause mortality

FGF23
Trajectory		 Low
Stable 		Low
Increasing 		Elevated
Increasing 		Elevated
Decreasing 		Elevated
Stable
Deaths
N (%) 		67 (38) 64 (43) 92 (34) 43 (39) 75 (33)
Models and Analysis
Unadjusted 1.04
(0.75-1.45)		 0.97
(0.69-1.36)		 0.93
(0.68-1.26)		 1.21
(0.83-1.77)		 Reference
Model 1: age, race, sex 0.73
(0.52-1.04)		 0.77
(0.54-1.09)		 0.78
(0.57-1.07)		 0.96
(0.65-1.41)		 Reference
Model 2: model 1 + diabetes, cardiovascular disease, years on dialysis, Kt/V and Flux randomization arms, AV access, serum albumin 0.65
(0.45-0.92)		 0.70
(0.49-1.00)		 0.73
(0.54-1.02)		 0.87
(0.59-1.29)		 Reference
Model 3: model 2 + calcium, phosphorus, PTH, 25(OH)D, 1,25(OH)2D, and inflammatory markers 0.62
(0.42-0.92)		 0.71
(0.48-1.03)		 0.75
(0.55-1.05)		 0.83
(0.55-1.24)		 Reference
Model 4: model 3 + baseline vitamin D analog use 0.61
(0.41-0.92)		 0.70
(0.48-1.03)		 0.75
(0.54-1.04)		 0.83
(0.55-1.23)		 Reference
Model 5: model 4 + residual kidney function 0.61
(0.41-0.91)		 0.70
(0.48-1.03)		 0.75
(0.54-1.04)		 0.82
(0.55-1.23)		 Reference